Author： Modrof J. Moritz C. Kolesnikova L. Konakova T. Hartlieb B. Randolf A. Muhlberger E. Becker S.
Publisher： Elsevier
ISSN： 0042-6822
Source： Virology, Vol.287, Iss.1, 2001-08, pp. : 171-182
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Vaccine Potential of Ebola Virus VP24, VP30, VP35, and VP40 Proteins
By Wilson J.A. Bray M. Bakken R. Hart M.K.
Virology, Vol. 286, Iss. 2, 2001-08 ,pp. :
Access to resources
Recommend
Variation in the Glycoprotein and VP35 Genes of Marburg Virus Strains
By Sanchez A. Trappier S.G. Stroher U. Nichol S.T. Bowen M.D. Feldmann H.
Virology, Vol. 240, Iss. 1, 1998-01 ,pp. :
Vesicular Release of Ebola Virus Matrix Protein VP40
By Timmins J. Scianimanico S. Schoehn G. Weissenhorn W.
Virology, Vol. 283, Iss. 1, 2001-04 ,pp. :
Proteolytic Processing of Marburg Virus Glycoprotein
By Volchkov V.E. Volchkova V.A. Stroher U. Becker S. Dolnik O. Cieplik M. Garten W. Klenk H.-D. Feldmann H.
Virology, Vol. 268, Iss. 1, 2000-03 ,pp. :